nodes	percent_of_prediction	percent_of_DWPC	metapath
Indacaterol—UGT1A1—hematologic cancer	0.326	0.81	CbGaD
Indacaterol—ABCB1—hematologic cancer	0.0762	0.19	CbGaD
Indacaterol—UGT1A1—Nilotinib—hematologic cancer	0.0436	0.109	CbGbCtD
Indacaterol—UGT1A1—Irinotecan—hematologic cancer	0.03	0.0747	CbGbCtD
Indacaterol—UGT1A1—Etoposide—hematologic cancer	0.024	0.0598	CbGbCtD
Indacaterol—ABCB1—Lenalidomide—hematologic cancer	0.0212	0.0528	CbGbCtD
Indacaterol—CYP3A4—Bexarotene—hematologic cancer	0.0127	0.0316	CbGbCtD
Indacaterol—ABCB1—Daunorubicin—hematologic cancer	0.0124	0.031	CbGbCtD
Indacaterol—ABCB1—Alitretinoin—hematologic cancer	0.0122	0.0303	CbGbCtD
Indacaterol—CYP3A4—Busulfan—hematologic cancer	0.0118	0.0294	CbGbCtD
Indacaterol—CYP3A4—Lomustine—hematologic cancer	0.0118	0.0294	CbGbCtD
Indacaterol—CYP3A4—Thiotepa—hematologic cancer	0.0105	0.0262	CbGbCtD
Indacaterol—ABCB1—Imatinib—hematologic cancer	0.00952	0.0237	CbGbCtD
Indacaterol—ABCB1—Nilotinib—hematologic cancer	0.00865	0.0216	CbGbCtD
Indacaterol—ABCB1—Vinorelbine—hematologic cancer	0.00858	0.0214	CbGbCtD
Indacaterol—CYP3A4—Methoxsalen—hematologic cancer	0.00819	0.0204	CbGbCtD
Indacaterol—CYP3A4—Bortezomib—hematologic cancer	0.00779	0.0194	CbGbCtD
Indacaterol—ABCB1—Dasatinib—hematologic cancer	0.00765	0.019	CbGbCtD
Indacaterol—ABCB1—Mitoxantrone—hematologic cancer	0.00756	0.0188	CbGbCtD
Indacaterol—CYP3A4—Daunorubicin—hematologic cancer	0.00745	0.0185	CbGbCtD
Indacaterol—ABCB1—Betamethasone—hematologic cancer	0.00673	0.0168	CbGbCtD
Indacaterol—ABCB1—Gemcitabine—hematologic cancer	0.00667	0.0166	CbGbCtD
Indacaterol—ABCB1—Prednisolone—hematologic cancer	0.00664	0.0165	CbGbCtD
Indacaterol—CYP3A4—Cytarabine—hematologic cancer	0.00657	0.0164	CbGbCtD
Indacaterol—CYP3A4—Teniposide—hematologic cancer	0.00647	0.0161	CbGbCtD
Indacaterol—ABCB1—Prednisone—hematologic cancer	0.00627	0.0156	CbGbCtD
Indacaterol—CYP3A4—Ifosfamide—hematologic cancer	0.00597	0.0149	CbGbCtD
Indacaterol—ABCB1—Irinotecan—hematologic cancer	0.00595	0.0148	CbGbCtD
Indacaterol—CYP3A4—Imatinib—hematologic cancer	0.00571	0.0142	CbGbCtD
Indacaterol—CYP3A4—Ruxolitinib—hematologic cancer	0.00537	0.0134	CbGbCtD
Indacaterol—ABCB1—Vinblastine—hematologic cancer	0.00529	0.0132	CbGbCtD
Indacaterol—ABCB1—Vincristine—hematologic cancer	0.0052	0.0129	CbGbCtD
Indacaterol—CYP3A4—Nilotinib—hematologic cancer	0.00519	0.0129	CbGbCtD
Indacaterol—CYP3A4—Vinorelbine—hematologic cancer	0.00514	0.0128	CbGbCtD
Indacaterol—ABCB1—Cisplatin—hematologic cancer	0.00485	0.0121	CbGbCtD
Indacaterol—ABCB1—Etoposide—hematologic cancer	0.00476	0.0119	CbGbCtD
Indacaterol—CYP3A4—Triamcinolone—hematologic cancer	0.0047	0.0117	CbGbCtD
Indacaterol—CYP3A4—Dasatinib—hematologic cancer	0.00458	0.0114	CbGbCtD
Indacaterol—CYP3A4—Mitoxantrone—hematologic cancer	0.00453	0.0113	CbGbCtD
Indacaterol—CYP3A4—Betamethasone—hematologic cancer	0.00403	0.01	CbGbCtD
Indacaterol—CYP3A4—Prednisolone—hematologic cancer	0.00398	0.00991	CbGbCtD
Indacaterol—ABCB1—Dexamethasone—hematologic cancer	0.00392	0.00975	CbGbCtD
Indacaterol—CYP3A4—Prednisone—hematologic cancer	0.00376	0.00936	CbGbCtD
Indacaterol—CYP3A4—Irinotecan—hematologic cancer	0.00356	0.00887	CbGbCtD
Indacaterol—ABCB1—Doxorubicin—hematologic cancer	0.00325	0.00809	CbGbCtD
Indacaterol—CYP3A4—Vinblastine—hematologic cancer	0.00317	0.00789	CbGbCtD
Indacaterol—ABCB1—Methotrexate—hematologic cancer	0.00315	0.00784	CbGbCtD
Indacaterol—CYP3A4—Vincristine—hematologic cancer	0.00312	0.00776	CbGbCtD
Indacaterol—CYP3A4—Etoposide—hematologic cancer	0.00285	0.00711	CbGbCtD
Indacaterol—CYP3A4—Dexamethasone—hematologic cancer	0.00235	0.00584	CbGbCtD
Indacaterol—CYP3A4—Doxorubicin—hematologic cancer	0.00195	0.00485	CbGbCtD
Indacaterol—Angina pectoris—Epirubicin—hematologic cancer	6.38e-05	0.000411	CcSEcCtD
Indacaterol—Hypersensitivity—Carmustine—hematologic cancer	6.33e-05	0.000408	CcSEcCtD
Indacaterol—Pruritus—Thalidomide—hematologic cancer	6.33e-05	0.000408	CcSEcCtD
Indacaterol—Nausea—Hydroxyurea—hematologic cancer	6.32e-05	0.000407	CcSEcCtD
Indacaterol—Myalgia—Triamcinolone—hematologic cancer	6.29e-05	0.000405	CcSEcCtD
Indacaterol—Pneumonia—Methotrexate—hematologic cancer	6.28e-05	0.000405	CcSEcCtD
Indacaterol—Hypersensitivity—Alitretinoin—hematologic cancer	6.27e-05	0.000404	CcSEcCtD
Indacaterol—Nasopharyngitis—Doxorubicin—hematologic cancer	6.27e-05	0.000404	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Cisplatin—hematologic cancer	6.26e-05	0.000404	CcSEcCtD
Indacaterol—Rash—Bortezomib—hematologic cancer	6.26e-05	0.000403	CcSEcCtD
Indacaterol—Dermatitis—Bortezomib—hematologic cancer	6.25e-05	0.000403	CcSEcCtD
Indacaterol—Infestation NOS—Methotrexate—hematologic cancer	6.24e-05	0.000402	CcSEcCtD
Indacaterol—Infestation—Methotrexate—hematologic cancer	6.24e-05	0.000402	CcSEcCtD
Indacaterol—Headache—Bortezomib—hematologic cancer	6.22e-05	0.000401	CcSEcCtD
Indacaterol—Rash—Bleomycin—hematologic cancer	6.21e-05	0.0004	CcSEcCtD
Indacaterol—Dermatitis—Bleomycin—hematologic cancer	6.2e-05	0.0004	CcSEcCtD
Indacaterol—Hypersensitivity—Ifosfamide—hematologic cancer	6.2e-05	0.0004	CcSEcCtD
Indacaterol—Dry mouth—Triamcinolone—hematologic cancer	6.15e-05	0.000396	CcSEcCtD
Indacaterol—Dizziness—Thiotepa—hematologic cancer	6.12e-05	0.000394	CcSEcCtD
Indacaterol—Rash—Vinorelbine—hematologic cancer	6.11e-05	0.000394	CcSEcCtD
Indacaterol—Dermatitis—Vinorelbine—hematologic cancer	6.1e-05	0.000393	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Epirubicin—hematologic cancer	6.09e-05	0.000392	CcSEcCtD
Indacaterol—Headache—Vinorelbine—hematologic cancer	6.07e-05	0.000391	CcSEcCtD
Indacaterol—Asthma—Doxorubicin—hematologic cancer	6.06e-05	0.000391	CcSEcCtD
Indacaterol—Immune system disorder—Prednisone—hematologic cancer	6.06e-05	0.00039	CcSEcCtD
Indacaterol—Hypersensitivity—Vincristine—hematologic cancer	6.05e-05	0.00039	CcSEcCtD
Indacaterol—Pruritus—Alitretinoin—hematologic cancer	6.03e-05	0.000388	CcSEcCtD
Indacaterol—Vertigo—Dexamethasone—hematologic cancer	6.02e-05	0.000388	CcSEcCtD
Indacaterol—Vertigo—Betamethasone—hematologic cancer	6.02e-05	0.000388	CcSEcCtD
Indacaterol—Infection—Triamcinolone—hematologic cancer	5.99e-05	0.000386	CcSEcCtD
Indacaterol—Paraesthesia—Etoposide—hematologic cancer	5.97e-05	0.000385	CcSEcCtD
Indacaterol—Pruritus—Ifosfamide—hematologic cancer	5.96e-05	0.000384	CcSEcCtD
Indacaterol—Dyspnoea—Etoposide—hematologic cancer	5.93e-05	0.000382	CcSEcCtD
Indacaterol—Dizziness—Thalidomide—hematologic cancer	5.92e-05	0.000381	CcSEcCtD
Indacaterol—Hyperglycaemia—Epirubicin—hematologic cancer	5.91e-05	0.000381	CcSEcCtD
Indacaterol—Angina pectoris—Doxorubicin—hematologic cancer	5.91e-05	0.000381	CcSEcCtD
Indacaterol—Nausea—Bortezomib—hematologic cancer	5.9e-05	0.00038	CcSEcCtD
Indacaterol—Hypersensitivity—Mitoxantrone—hematologic cancer	5.89e-05	0.000379	CcSEcCtD
Indacaterol—Hypersensitivity—Irinotecan—hematologic cancer	5.89e-05	0.000379	CcSEcCtD
Indacaterol—Paraesthesia—Prednisolone—hematologic cancer	5.89e-05	0.000379	CcSEcCtD
Indacaterol—Tachycardia—Triamcinolone—hematologic cancer	5.88e-05	0.000379	CcSEcCtD
Indacaterol—Pneumonia—Epirubicin—hematologic cancer	5.88e-05	0.000379	CcSEcCtD
Indacaterol—Nausea—Bleomycin—hematologic cancer	5.85e-05	0.000377	CcSEcCtD
Indacaterol—Infestation NOS—Epirubicin—hematologic cancer	5.84e-05	0.000377	CcSEcCtD
Indacaterol—Infestation—Epirubicin—hematologic cancer	5.84e-05	0.000377	CcSEcCtD
Indacaterol—Malnutrition—Prednisone—hematologic cancer	5.84e-05	0.000376	CcSEcCtD
Indacaterol—Rash—Thiotepa—hematologic cancer	5.84e-05	0.000376	CcSEcCtD
Indacaterol—Dermatitis—Thiotepa—hematologic cancer	5.83e-05	0.000376	CcSEcCtD
Indacaterol—Headache—Thiotepa—hematologic cancer	5.8e-05	0.000374	CcSEcCtD
Indacaterol—Nausea—Vinorelbine—hematologic cancer	5.76e-05	0.000371	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Etoposide—hematologic cancer	5.74e-05	0.00037	CcSEcCtD
Indacaterol—Myalgia—Dexamethasone—hematologic cancer	5.71e-05	0.000368	CcSEcCtD
Indacaterol—Myalgia—Betamethasone—hematologic cancer	5.71e-05	0.000368	CcSEcCtD
Indacaterol—Dizziness—Carmustine—hematologic cancer	5.68e-05	0.000366	CcSEcCtD
Indacaterol—Rash—Thalidomide—hematologic cancer	5.64e-05	0.000364	CcSEcCtD
Indacaterol—Dermatitis—Thalidomide—hematologic cancer	5.64e-05	0.000363	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Doxorubicin—hematologic cancer	5.64e-05	0.000363	CcSEcCtD
Indacaterol—Dizziness—Alitretinoin—hematologic cancer	5.63e-05	0.000363	CcSEcCtD
Indacaterol—Headache—Thalidomide—hematologic cancer	5.61e-05	0.000361	CcSEcCtD
Indacaterol—Dizziness—Ifosfamide—hematologic cancer	5.57e-05	0.000359	CcSEcCtD
Indacaterol—Pruritus—Gemcitabine—hematologic cancer	5.51e-05	0.000355	CcSEcCtD
Indacaterol—Nausea—Thiotepa—hematologic cancer	5.5e-05	0.000354	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	5.49e-05	0.000354	CcSEcCtD
Indacaterol—Sinusitis—Epirubicin—hematologic cancer	5.48e-05	0.000353	CcSEcCtD
Indacaterol—Hyperglycaemia—Doxorubicin—hematologic cancer	5.47e-05	0.000352	CcSEcCtD
Indacaterol—Pneumonia—Doxorubicin—hematologic cancer	5.44e-05	0.00035	CcSEcCtD
Indacaterol—Infection—Betamethasone—hematologic cancer	5.44e-05	0.00035	CcSEcCtD
Indacaterol—Infection—Dexamethasone—hematologic cancer	5.44e-05	0.00035	CcSEcCtD
Indacaterol—Dizziness—Vincristine—hematologic cancer	5.43e-05	0.00035	CcSEcCtD
Indacaterol—Rash—Carmustine—hematologic cancer	5.42e-05	0.000349	CcSEcCtD
Indacaterol—Dermatitis—Carmustine—hematologic cancer	5.42e-05	0.000349	CcSEcCtD
Indacaterol—Paraesthesia—Triamcinolone—hematologic cancer	5.41e-05	0.000349	CcSEcCtD
Indacaterol—Infestation NOS—Doxorubicin—hematologic cancer	5.41e-05	0.000348	CcSEcCtD
Indacaterol—Infestation—Doxorubicin—hematologic cancer	5.41e-05	0.000348	CcSEcCtD
Indacaterol—Anaemia—Prednisone—hematologic cancer	5.4e-05	0.000348	CcSEcCtD
Indacaterol—Headache—Carmustine—hematologic cancer	5.39e-05	0.000347	CcSEcCtD
Indacaterol—Dyspnoea—Triamcinolone—hematologic cancer	5.38e-05	0.000346	CcSEcCtD
Indacaterol—Rash—Alitretinoin—hematologic cancer	5.37e-05	0.000346	CcSEcCtD
Indacaterol—Nervous system disorder—Betamethasone—hematologic cancer	5.37e-05	0.000346	CcSEcCtD
Indacaterol—Nervous system disorder—Dexamethasone—hematologic cancer	5.37e-05	0.000346	CcSEcCtD
Indacaterol—Dermatitis—Alitretinoin—hematologic cancer	5.36e-05	0.000346	CcSEcCtD
Indacaterol—Hypersensitivity—Cisplatin—hematologic cancer	5.35e-05	0.000345	CcSEcCtD
Indacaterol—Tachycardia—Betamethasone—hematologic cancer	5.34e-05	0.000344	CcSEcCtD
Indacaterol—Tachycardia—Dexamethasone—hematologic cancer	5.34e-05	0.000344	CcSEcCtD
Indacaterol—Headache—Alitretinoin—hematologic cancer	5.34e-05	0.000344	CcSEcCtD
Indacaterol—Nausea—Thalidomide—hematologic cancer	5.32e-05	0.000343	CcSEcCtD
Indacaterol—Rash—Ifosfamide—hematologic cancer	5.31e-05	0.000342	CcSEcCtD
Indacaterol—Dermatitis—Ifosfamide—hematologic cancer	5.3e-05	0.000342	CcSEcCtD
Indacaterol—Dizziness—Irinotecan—hematologic cancer	5.29e-05	0.000341	CcSEcCtD
Indacaterol—Vertigo—Prednisone—hematologic cancer	5.25e-05	0.000338	CcSEcCtD
Indacaterol—Cardiac disorder—Methotrexate—hematologic cancer	5.2e-05	0.000335	CcSEcCtD
Indacaterol—Rash—Vincristine—hematologic cancer	5.17e-05	0.000333	CcSEcCtD
Indacaterol—Dermatitis—Vincristine—hematologic cancer	5.17e-05	0.000333	CcSEcCtD
Indacaterol—Oedema peripheral—Epirubicin—hematologic cancer	5.17e-05	0.000333	CcSEcCtD
Indacaterol—Connective tissue disorder—Epirubicin—hematologic cancer	5.15e-05	0.000332	CcSEcCtD
Indacaterol—Headache—Vincristine—hematologic cancer	5.14e-05	0.000331	CcSEcCtD
Indacaterol—Nausea—Carmustine—hematologic cancer	5.11e-05	0.000329	CcSEcCtD
Indacaterol—Sinusitis—Doxorubicin—hematologic cancer	5.07e-05	0.000327	CcSEcCtD
Indacaterol—Immune system disorder—Methotrexate—hematologic cancer	5.06e-05	0.000326	CcSEcCtD
Indacaterol—Nausea—Alitretinoin—hematologic cancer	5.06e-05	0.000326	CcSEcCtD
Indacaterol—Mediastinal disorder—Methotrexate—hematologic cancer	5.05e-05	0.000326	CcSEcCtD
Indacaterol—Rash—Irinotecan—hematologic cancer	5.04e-05	0.000325	CcSEcCtD
Indacaterol—Rash—Mitoxantrone—hematologic cancer	5.04e-05	0.000325	CcSEcCtD
Indacaterol—Dermatitis—Mitoxantrone—hematologic cancer	5.03e-05	0.000324	CcSEcCtD
Indacaterol—Dermatitis—Irinotecan—hematologic cancer	5.03e-05	0.000324	CcSEcCtD
Indacaterol—Headache—Mitoxantrone—hematologic cancer	5.01e-05	0.000323	CcSEcCtD
Indacaterol—Headache—Irinotecan—hematologic cancer	5.01e-05	0.000323	CcSEcCtD
Indacaterol—Nausea—Ifosfamide—hematologic cancer	5e-05	0.000322	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	4.98e-05	0.000321	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Betamethasone—hematologic cancer	4.98e-05	0.000321	CcSEcCtD
Indacaterol—Myalgia—Prednisone—hematologic cancer	4.97e-05	0.00032	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	4.94e-05	0.000318	CcSEcCtD
Indacaterol—Paraesthesia—Betamethasone—hematologic cancer	4.91e-05	0.000317	CcSEcCtD
Indacaterol—Paraesthesia—Dexamethasone—hematologic cancer	4.91e-05	0.000317	CcSEcCtD
Indacaterol—Rash—Gemcitabine—hematologic cancer	4.91e-05	0.000316	CcSEcCtD
Indacaterol—Dermatitis—Gemcitabine—hematologic cancer	4.9e-05	0.000316	CcSEcCtD
Indacaterol—Hypersensitivity—Etoposide—hematologic cancer	4.9e-05	0.000316	CcSEcCtD
Indacaterol—Malnutrition—Methotrexate—hematologic cancer	4.88e-05	0.000314	CcSEcCtD
Indacaterol—Headache—Gemcitabine—hematologic cancer	4.88e-05	0.000314	CcSEcCtD
Indacaterol—Nausea—Vincristine—hematologic cancer	4.87e-05	0.000314	CcSEcCtD
Indacaterol—Cardiac disorder—Epirubicin—hematologic cancer	4.87e-05	0.000314	CcSEcCtD
Indacaterol—Hypersensitivity—Prednisolone—hematologic cancer	4.83e-05	0.000311	CcSEcCtD
Indacaterol—Oedema peripheral—Doxorubicin—hematologic cancer	4.78e-05	0.000308	CcSEcCtD
Indacaterol—Connective tissue disorder—Doxorubicin—hematologic cancer	4.77e-05	0.000307	CcSEcCtD
Indacaterol—Nausea—Mitoxantrone—hematologic cancer	4.75e-05	0.000306	CcSEcCtD
Indacaterol—Nausea—Irinotecan—hematologic cancer	4.75e-05	0.000306	CcSEcCtD
Indacaterol—Immune system disorder—Epirubicin—hematologic cancer	4.74e-05	0.000305	CcSEcCtD
Indacaterol—Infection—Prednisone—hematologic cancer	4.73e-05	0.000305	CcSEcCtD
Indacaterol—Mediastinal disorder—Epirubicin—hematologic cancer	4.73e-05	0.000305	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Dexamethasone—hematologic cancer	4.72e-05	0.000304	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Betamethasone—hematologic cancer	4.72e-05	0.000304	CcSEcCtD
Indacaterol—Pruritus—Etoposide—hematologic cancer	4.7e-05	0.000303	CcSEcCtD
Indacaterol—Nervous system disorder—Prednisone—hematologic cancer	4.67e-05	0.000301	CcSEcCtD
Indacaterol—Tachycardia—Prednisone—hematologic cancer	4.65e-05	0.0003	CcSEcCtD
Indacaterol—Skin disorder—Prednisone—hematologic cancer	4.63e-05	0.000298	CcSEcCtD
Indacaterol—Nausea—Gemcitabine—hematologic cancer	4.62e-05	0.000298	CcSEcCtD
Indacaterol—Rash—Cisplatin—hematologic cancer	4.58e-05	0.000295	CcSEcCtD
Indacaterol—Dermatitis—Cisplatin—hematologic cancer	4.57e-05	0.000295	CcSEcCtD
Indacaterol—Malnutrition—Epirubicin—hematologic cancer	4.57e-05	0.000294	CcSEcCtD
Indacaterol—Anaemia—Methotrexate—hematologic cancer	4.51e-05	0.000291	CcSEcCtD
Indacaterol—Cardiac disorder—Doxorubicin—hematologic cancer	4.5e-05	0.00029	CcSEcCtD
Indacaterol—Hypersensitivity—Triamcinolone—hematologic cancer	4.44e-05	0.000286	CcSEcCtD
Indacaterol—Dizziness—Etoposide—hematologic cancer	4.4e-05	0.000283	CcSEcCtD
Indacaterol—Muscle spasms—Epirubicin—hematologic cancer	4.39e-05	0.000283	CcSEcCtD
Indacaterol—Immune system disorder—Doxorubicin—hematologic cancer	4.38e-05	0.000282	CcSEcCtD
Indacaterol—Vertigo—Methotrexate—hematologic cancer	4.38e-05	0.000282	CcSEcCtD
Indacaterol—Mediastinal disorder—Doxorubicin—hematologic cancer	4.37e-05	0.000282	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Prednisone—hematologic cancer	4.34e-05	0.00028	CcSEcCtD
Indacaterol—Dizziness—Prednisolone—hematologic cancer	4.34e-05	0.000279	CcSEcCtD
Indacaterol—Nausea—Cisplatin—hematologic cancer	4.31e-05	0.000278	CcSEcCtD
Indacaterol—Paraesthesia—Prednisone—hematologic cancer	4.28e-05	0.000276	CcSEcCtD
Indacaterol—Pruritus—Triamcinolone—hematologic cancer	4.27e-05	0.000275	CcSEcCtD
Indacaterol—Cough—Methotrexate—hematologic cancer	4.26e-05	0.000274	CcSEcCtD
Indacaterol—Malnutrition—Doxorubicin—hematologic cancer	4.22e-05	0.000272	CcSEcCtD
Indacaterol—Anaemia—Epirubicin—hematologic cancer	4.22e-05	0.000272	CcSEcCtD
Indacaterol—Rash—Etoposide—hematologic cancer	4.19e-05	0.00027	CcSEcCtD
Indacaterol—Dermatitis—Etoposide—hematologic cancer	4.19e-05	0.00027	CcSEcCtD
Indacaterol—Headache—Etoposide—hematologic cancer	4.16e-05	0.000268	CcSEcCtD
Indacaterol—Myalgia—Methotrexate—hematologic cancer	4.15e-05	0.000268	CcSEcCtD
Indacaterol—Chest pain—Methotrexate—hematologic cancer	4.15e-05	0.000268	CcSEcCtD
Indacaterol—Rash—Prednisolone—hematologic cancer	4.13e-05	0.000266	CcSEcCtD
Indacaterol—Dermatitis—Prednisolone—hematologic cancer	4.13e-05	0.000266	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	4.13e-05	0.000266	CcSEcCtD
Indacaterol—Headache—Prednisolone—hematologic cancer	4.11e-05	0.000265	CcSEcCtD
Indacaterol—Vertigo—Epirubicin—hematologic cancer	4.1e-05	0.000264	CcSEcCtD
Indacaterol—Muscle spasms—Doxorubicin—hematologic cancer	4.06e-05	0.000262	CcSEcCtD
Indacaterol—Palpitations—Epirubicin—hematologic cancer	4.04e-05	0.00026	CcSEcCtD
Indacaterol—Dizziness—Triamcinolone—hematologic cancer	3.99e-05	0.000257	CcSEcCtD
Indacaterol—Cough—Epirubicin—hematologic cancer	3.98e-05	0.000257	CcSEcCtD
Indacaterol—Infection—Methotrexate—hematologic cancer	3.96e-05	0.000255	CcSEcCtD
Indacaterol—Nausea—Etoposide—hematologic cancer	3.95e-05	0.000254	CcSEcCtD
Indacaterol—Nervous system disorder—Methotrexate—hematologic cancer	3.91e-05	0.000252	CcSEcCtD
Indacaterol—Anaemia—Doxorubicin—hematologic cancer	3.9e-05	0.000252	CcSEcCtD
Indacaterol—Nausea—Prednisolone—hematologic cancer	3.89e-05	0.000251	CcSEcCtD
Indacaterol—Chest pain—Epirubicin—hematologic cancer	3.89e-05	0.000251	CcSEcCtD
Indacaterol—Myalgia—Epirubicin—hematologic cancer	3.89e-05	0.000251	CcSEcCtD
Indacaterol—Pruritus—Betamethasone—hematologic cancer	3.87e-05	0.000249	CcSEcCtD
Indacaterol—Pruritus—Dexamethasone—hematologic cancer	3.87e-05	0.000249	CcSEcCtD
Indacaterol—Skin disorder—Methotrexate—hematologic cancer	3.87e-05	0.000249	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	3.86e-05	0.000249	CcSEcCtD
Indacaterol—Rash—Triamcinolone—hematologic cancer	3.8e-05	0.000245	CcSEcCtD
Indacaterol—Dry mouth—Epirubicin—hematologic cancer	3.8e-05	0.000245	CcSEcCtD
Indacaterol—Dermatitis—Triamcinolone—hematologic cancer	3.8e-05	0.000245	CcSEcCtD
Indacaterol—Vertigo—Doxorubicin—hematologic cancer	3.8e-05	0.000245	CcSEcCtD
Indacaterol—Headache—Triamcinolone—hematologic cancer	3.78e-05	0.000243	CcSEcCtD
Indacaterol—Palpitations—Doxorubicin—hematologic cancer	3.73e-05	0.000241	CcSEcCtD
Indacaterol—Infection—Epirubicin—hematologic cancer	3.7e-05	0.000239	CcSEcCtD
Indacaterol—Cough—Doxorubicin—hematologic cancer	3.69e-05	0.000238	CcSEcCtD
Indacaterol—Nervous system disorder—Epirubicin—hematologic cancer	3.65e-05	0.000235	CcSEcCtD
Indacaterol—Tachycardia—Epirubicin—hematologic cancer	3.64e-05	0.000234	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Methotrexate—hematologic cancer	3.63e-05	0.000234	CcSEcCtD
Indacaterol—Skin disorder—Epirubicin—hematologic cancer	3.62e-05	0.000233	CcSEcCtD
Indacaterol—Dizziness—Betamethasone—hematologic cancer	3.62e-05	0.000233	CcSEcCtD
Indacaterol—Dizziness—Dexamethasone—hematologic cancer	3.62e-05	0.000233	CcSEcCtD
Indacaterol—Myalgia—Doxorubicin—hematologic cancer	3.6e-05	0.000232	CcSEcCtD
Indacaterol—Chest pain—Doxorubicin—hematologic cancer	3.6e-05	0.000232	CcSEcCtD
Indacaterol—Nausea—Triamcinolone—hematologic cancer	3.58e-05	0.000231	CcSEcCtD
Indacaterol—Paraesthesia—Methotrexate—hematologic cancer	3.58e-05	0.00023	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	3.57e-05	0.00023	CcSEcCtD
Indacaterol—Dyspnoea—Methotrexate—hematologic cancer	3.55e-05	0.000229	CcSEcCtD
Indacaterol—Dry mouth—Doxorubicin—hematologic cancer	3.52e-05	0.000227	CcSEcCtD
Indacaterol—Hypersensitivity—Prednisone—hematologic cancer	3.51e-05	0.000226	CcSEcCtD
Indacaterol—Rash—Dexamethasone—hematologic cancer	3.45e-05	0.000222	CcSEcCtD
Indacaterol—Rash—Betamethasone—hematologic cancer	3.45e-05	0.000222	CcSEcCtD
Indacaterol—Dermatitis—Dexamethasone—hematologic cancer	3.45e-05	0.000222	CcSEcCtD
Indacaterol—Dermatitis—Betamethasone—hematologic cancer	3.45e-05	0.000222	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Methotrexate—hematologic cancer	3.44e-05	0.000222	CcSEcCtD
Indacaterol—Headache—Dexamethasone—hematologic cancer	3.43e-05	0.000221	CcSEcCtD
Indacaterol—Headache—Betamethasone—hematologic cancer	3.43e-05	0.000221	CcSEcCtD
Indacaterol—Infection—Doxorubicin—hematologic cancer	3.43e-05	0.000221	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Epirubicin—hematologic cancer	3.4e-05	0.000219	CcSEcCtD
Indacaterol—Nervous system disorder—Doxorubicin—hematologic cancer	3.38e-05	0.000218	CcSEcCtD
Indacaterol—Pruritus—Prednisone—hematologic cancer	3.37e-05	0.000217	CcSEcCtD
Indacaterol—Tachycardia—Doxorubicin—hematologic cancer	3.37e-05	0.000217	CcSEcCtD
Indacaterol—Skin disorder—Doxorubicin—hematologic cancer	3.35e-05	0.000216	CcSEcCtD
Indacaterol—Paraesthesia—Epirubicin—hematologic cancer	3.35e-05	0.000216	CcSEcCtD
Indacaterol—Dyspnoea—Epirubicin—hematologic cancer	3.32e-05	0.000214	CcSEcCtD
Indacaterol—Nausea—Dexamethasone—hematologic cancer	3.25e-05	0.000209	CcSEcCtD
Indacaterol—Nausea—Betamethasone—hematologic cancer	3.25e-05	0.000209	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.22e-05	0.000207	CcSEcCtD
Indacaterol—Dizziness—Prednisone—hematologic cancer	3.15e-05	0.000203	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	3.14e-05	0.000202	CcSEcCtD
Indacaterol—Paraesthesia—Doxorubicin—hematologic cancer	3.1e-05	0.0002	CcSEcCtD
Indacaterol—Dyspnoea—Doxorubicin—hematologic cancer	3.07e-05	0.000198	CcSEcCtD
Indacaterol—Rash—Prednisone—hematologic cancer	3e-05	0.000194	CcSEcCtD
Indacaterol—Dermatitis—Prednisone—hematologic cancer	3e-05	0.000193	CcSEcCtD
Indacaterol—Headache—Prednisone—hematologic cancer	2.98e-05	0.000192	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.98e-05	0.000192	CcSEcCtD
Indacaterol—Hypersensitivity—Methotrexate—hematologic cancer	2.93e-05	0.000189	CcSEcCtD
Indacaterol—Nausea—Prednisone—hematologic cancer	2.83e-05	0.000182	CcSEcCtD
Indacaterol—Pruritus—Methotrexate—hematologic cancer	2.82e-05	0.000182	CcSEcCtD
Indacaterol—Hypersensitivity—Epirubicin—hematologic cancer	2.75e-05	0.000177	CcSEcCtD
Indacaterol—Pruritus—Epirubicin—hematologic cancer	2.64e-05	0.00017	CcSEcCtD
Indacaterol—Dizziness—Methotrexate—hematologic cancer	2.63e-05	0.00017	CcSEcCtD
Indacaterol—Hypersensitivity—Doxorubicin—hematologic cancer	2.54e-05	0.000164	CcSEcCtD
Indacaterol—Rash—Methotrexate—hematologic cancer	2.51e-05	0.000162	CcSEcCtD
Indacaterol—Dermatitis—Methotrexate—hematologic cancer	2.51e-05	0.000162	CcSEcCtD
Indacaterol—Headache—Methotrexate—hematologic cancer	2.49e-05	0.000161	CcSEcCtD
Indacaterol—Dizziness—Epirubicin—hematologic cancer	2.46e-05	0.000159	CcSEcCtD
Indacaterol—Pruritus—Doxorubicin—hematologic cancer	2.44e-05	0.000157	CcSEcCtD
Indacaterol—Nausea—Methotrexate—hematologic cancer	2.37e-05	0.000152	CcSEcCtD
Indacaterol—Rash—Epirubicin—hematologic cancer	2.35e-05	0.000151	CcSEcCtD
Indacaterol—Dermatitis—Epirubicin—hematologic cancer	2.35e-05	0.000151	CcSEcCtD
Indacaterol—Headache—Epirubicin—hematologic cancer	2.33e-05	0.00015	CcSEcCtD
Indacaterol—Dizziness—Doxorubicin—hematologic cancer	2.28e-05	0.000147	CcSEcCtD
Indacaterol—Nausea—Epirubicin—hematologic cancer	2.21e-05	0.000143	CcSEcCtD
Indacaterol—Rash—Doxorubicin—hematologic cancer	2.17e-05	0.00014	CcSEcCtD
Indacaterol—Dermatitis—Doxorubicin—hematologic cancer	2.17e-05	0.00014	CcSEcCtD
Indacaterol—Headache—Doxorubicin—hematologic cancer	2.16e-05	0.000139	CcSEcCtD
Indacaterol—Nausea—Doxorubicin—hematologic cancer	2.05e-05	0.000132	CcSEcCtD
Indacaterol—ADRB1—Signaling Pathways—GRB2—hematologic cancer	6.64e-06	0.000161	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—PIK3CD—hematologic cancer	6.63e-06	0.00016	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PDGFA—hematologic cancer	6.63e-06	0.00016	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—MTAP—hematologic cancer	6.61e-06	0.00016	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—JAK2—hematologic cancer	6.56e-06	0.000159	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—KITLG—hematologic cancer	6.53e-06	0.000158	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—MAP2K1—hematologic cancer	6.53e-06	0.000158	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—NUP98—hematologic cancer	6.52e-06	0.000158	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—GRB2—hematologic cancer	6.5e-06	0.000157	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—PIK3CD—hematologic cancer	6.49e-06	0.000157	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PDGFA—hematologic cancer	6.48e-06	0.000157	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—KITLG—hematologic cancer	6.39e-06	0.000154	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—STAT5A—hematologic cancer	6.38e-06	0.000154	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—PIK3CB—hematologic cancer	6.37e-06	0.000154	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ADCY7—hematologic cancer	6.33e-06	0.000153	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—NCOA3—hematologic cancer	6.33e-06	0.000153	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CDKN2B—hematologic cancer	6.33e-06	0.000153	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—NUP214—hematologic cancer	6.29e-06	0.000152	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—PIK3R1—hematologic cancer	6.26e-06	0.000151	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—STAT5A—hematologic cancer	6.25e-06	0.000151	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—PIK3CB—hematologic cancer	6.23e-06	0.000151	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CDKN2B—hematologic cancer	6.19e-06	0.00015	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ABCG2—hematologic cancer	6.16e-06	0.000149	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—MTR—hematologic cancer	6.16e-06	0.000149	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—PIK3R1—hematologic cancer	6.13e-06	0.000148	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CD86—hematologic cancer	6.12e-06	0.000148	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—JAK2—hematologic cancer	6.09e-06	0.000147	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PIK3CG—hematologic cancer	6.04e-06	0.000146	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ENO2—hematologic cancer	6.04e-06	0.000146	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—HES1—hematologic cancer	6.04e-06	0.000146	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—NCOR1—hematologic cancer	6e-06	0.000145	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CD86—hematologic cancer	5.99e-06	0.000145	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—JAK2—hematologic cancer	5.95e-06	0.000144	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CSF2—hematologic cancer	5.94e-06	0.000143	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—FGF1—hematologic cancer	5.94e-06	0.000143	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—HES1—hematologic cancer	5.91e-06	0.000143	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—FHL2—hematologic cancer	5.89e-06	0.000142	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—NCOR1—hematologic cancer	5.87e-06	0.000142	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—GSTT1—hematologic cancer	5.86e-06	0.000142	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—FOXO1—hematologic cancer	5.85e-06	0.000141	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—IL2—hematologic cancer	5.85e-06	0.000141	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PDGFRB—hematologic cancer	5.84e-06	0.000141	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—FGF1—hematologic cancer	5.81e-06	0.00014	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CSF2—hematologic cancer	5.81e-06	0.00014	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—PIK3CB—hematologic cancer	5.78e-06	0.00014	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—AGRN—hematologic cancer	5.78e-06	0.00014	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PDGFRA—hematologic cancer	5.75e-06	0.000139	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—JAK1—hematologic cancer	5.73e-06	0.000138	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PRKCG—hematologic cancer	5.73e-06	0.000138	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—SDC1—hematologic cancer	5.73e-06	0.000138	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—FOXO1—hematologic cancer	5.72e-06	0.000138	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—IL2—hematologic cancer	5.72e-06	0.000138	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PDGFRB—hematologic cancer	5.71e-06	0.000138	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	5.69e-06	0.000137	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—PIK3CB—hematologic cancer	5.66e-06	0.000137	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PDGFRA—hematologic cancer	5.62e-06	0.000136	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—JAK1—hematologic cancer	5.6e-06	0.000135	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PRKCG—hematologic cancer	5.6e-06	0.000135	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—CREBBP—hematologic cancer	5.6e-06	0.000135	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.49e-06	0.000133	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—IDH2—hematologic cancer	5.47e-06	0.000132	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—HMMR—hematologic cancer	5.47e-06	0.000132	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—IL2RA—hematologic cancer	5.35e-06	0.000129	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PIK3CD—hematologic cancer	5.31e-06	0.000128	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—IL2—hematologic cancer	5.31e-06	0.000128	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—TERT—hematologic cancer	5.29e-06	0.000128	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—ALB—hematologic cancer	5.24e-06	0.000127	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—IL2RA—hematologic cancer	5.23e-06	0.000127	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—IL2—hematologic cancer	5.19e-06	0.000126	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—TERT—hematologic cancer	5.17e-06	0.000125	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PDGFB—hematologic cancer	5.16e-06	0.000125	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ARNTL—hematologic cancer	5.15e-06	0.000124	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	5.13e-06	0.000124	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PDGFB—hematologic cancer	5.05e-06	0.000122	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—TSC2—hematologic cancer	5.05e-06	0.000122	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PIK3R1—hematologic cancer	5.01e-06	0.000121	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ACP5—hematologic cancer	5.01e-06	0.000121	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CA9—hematologic cancer	5.01e-06	0.000121	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—NCOR2—hematologic cancer	4.94e-06	0.000119	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—TSC2—hematologic cancer	4.94e-06	0.000119	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CD44—hematologic cancer	4.87e-06	0.000118	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—NQO1—hematologic cancer	4.87e-06	0.000118	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—FGFR3—hematologic cancer	4.85e-06	0.000117	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MAPK14—hematologic cancer	4.81e-06	0.000116	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—FGFR3—hematologic cancer	4.75e-06	0.000115	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—ESR1—hematologic cancer	4.72e-06	0.000114	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—IDH1—hematologic cancer	4.71e-06	0.000114	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MAPK14—hematologic cancer	4.7e-06	0.000114	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—FN1—hematologic cancer	4.66e-06	0.000113	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GSTO1—hematologic cancer	4.66e-06	0.000113	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—TXN—hematologic cancer	4.66e-06	0.000113	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ABCC3—hematologic cancer	4.66e-06	0.000113	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PIK3CB—hematologic cancer	4.63e-06	0.000112	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—ESR1—hematologic cancer	4.61e-06	0.000112	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CYCS—hematologic cancer	4.61e-06	0.000111	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—BAD—hematologic cancer	4.6e-06	0.000111	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—NFKBIA—hematologic cancer	4.6e-06	0.000111	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—HSP90AA1—hematologic cancer	4.58e-06	0.000111	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—NOTCH1—hematologic cancer	4.56e-06	0.00011	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—FN1—hematologic cancer	4.56e-06	0.00011	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—SPHK1—hematologic cancer	4.56e-06	0.00011	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—NFKBIA—hematologic cancer	4.5e-06	0.000109	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—BAD—hematologic cancer	4.5e-06	0.000109	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CD80—hematologic cancer	4.47e-06	0.000108	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—NOTCH1—hematologic cancer	4.46e-06	0.000108	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PIK3CG—hematologic cancer	4.46e-06	0.000108	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—KIT—hematologic cancer	4.46e-06	0.000108	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—NRAS—hematologic cancer	4.46e-06	0.000108	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PTPN11—hematologic cancer	4.38e-06	0.000106	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—UGT1A1—hematologic cancer	4.38e-06	0.000106	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CD80—hematologic cancer	4.37e-06	0.000106	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PIK3CG—hematologic cancer	4.36e-06	0.000105	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—KIT—hematologic cancer	4.36e-06	0.000105	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—NRAS—hematologic cancer	4.36e-06	0.000105	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PTPN11—hematologic cancer	4.28e-06	0.000104	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—MAPK3—hematologic cancer	4.27e-06	0.000103	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CRABP1—hematologic cancer	4.26e-06	0.000103	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—SLC22A1—hematologic cancer	4.26e-06	0.000103	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CREB1—hematologic cancer	4.24e-06	0.000103	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—BRAF—hematologic cancer	4.19e-06	0.000101	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—MAPK3—hematologic cancer	4.18e-06	0.000101	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CCL2—hematologic cancer	4.15e-06	0.0001	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CREB1—hematologic cancer	4.15e-06	0.0001	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ALOX5—hematologic cancer	4.15e-06	0.0001	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—IL6R—hematologic cancer	4.14e-06	0.0001	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CREBBP—hematologic cancer	4.13e-06	9.99e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—BRAF—hematologic cancer	4.1e-06	9.91e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—GSTP1—hematologic cancer	4.06e-06	9.82e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CCL2—hematologic cancer	4.06e-06	9.82e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—IL6R—hematologic cancer	4.05e-06	9.79e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CREBBP—hematologic cancer	4.04e-06	9.77e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—NUP98—hematologic cancer	4.02e-06	9.71e-05	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PTEN—hematologic cancer	4e-06	9.67e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MAP2K1—hematologic cancer	3.94e-06	9.54e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PIK3CD—hematologic cancer	3.92e-06	9.47e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.9e-06	9.43e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.9e-06	9.43e-05	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—PIK3CA—hematologic cancer	3.88e-06	9.38e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—NUP214—hematologic cancer	3.87e-06	9.36e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MAP2K1—hematologic cancer	3.86e-06	9.33e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—KRAS—hematologic cancer	3.84e-06	9.27e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PIK3CD—hematologic cancer	3.83e-06	9.27e-05	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—EP300—hematologic cancer	3.81e-06	9.22e-05	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—PIK3CA—hematologic cancer	3.8e-06	9.18e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—MTR—hematologic cancer	3.79e-06	9.17e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.79e-06	9.17e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—KRAS—hematologic cancer	3.75e-06	9.07e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—FGF2—hematologic cancer	3.75e-06	9.07e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—NCOR1—hematologic cancer	3.73e-06	9.02e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—GSTM1—hematologic cancer	3.73e-06	9.02e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ENO2—hematologic cancer	3.72e-06	9e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PIK3R1—hematologic cancer	3.7e-06	8.94e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—FGF2—hematologic cancer	3.67e-06	8.87e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PIK3R1—hematologic cancer	3.62e-06	8.75e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.61e-06	8.73e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—JAK2—hematologic cancer	3.6e-06	8.69e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—SDC1—hematologic cancer	3.53e-06	8.53e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—PIK3CA—hematologic cancer	3.52e-06	8.52e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—JAK2—hematologic cancer	3.52e-06	8.5e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MDM2—hematologic cancer	3.51e-06	8.49e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—PIK3CA—hematologic cancer	3.45e-06	8.33e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MDM2—hematologic cancer	3.43e-06	8.3e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MTOR—hematologic cancer	3.42e-06	8.26e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PIK3CB—hematologic cancer	3.42e-06	8.26e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PIK3CB—hematologic cancer	3.34e-06	8.08e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MTOR—hematologic cancer	3.34e-06	8.08e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—MTHFR—hematologic cancer	3.3e-06	7.97e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—HRAS—hematologic cancer	3.26e-06	7.88e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CDKN1B—hematologic cancer	3.21e-06	7.75e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—HRAS—hematologic cancer	3.19e-06	7.71e-05	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—AKT1—hematologic cancer	3.17e-06	7.66e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CASP3—hematologic cancer	3.14e-06	7.59e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—IL2—hematologic cancer	3.14e-06	7.58e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CDKN1B—hematologic cancer	3.14e-06	7.58e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—IL6—hematologic cancer	3.12e-06	7.54e-05	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—AKT1—hematologic cancer	3.1e-06	7.5e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CASP3—hematologic cancer	3.07e-06	7.43e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—IL2—hematologic cancer	3.07e-06	7.42e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CCND1—hematologic cancer	3.06e-06	7.39e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—IL6—hematologic cancer	3.05e-06	7.38e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—JUN—hematologic cancer	3.05e-06	7.38e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CD44—hematologic cancer	3e-06	7.25e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—NQO1—hematologic cancer	3e-06	7.25e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CCND1—hematologic cancer	2.99e-06	7.23e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—JUN—hematologic cancer	2.98e-06	7.22e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CDKN1A—hematologic cancer	2.96e-06	7.15e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PTEN—hematologic cancer	2.95e-06	7.13e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CDKN1A—hematologic cancer	2.89e-06	6.99e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MAPK8—hematologic cancer	2.89e-06	6.98e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PTEN—hematologic cancer	2.89e-06	6.98e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—AKT1—hematologic cancer	2.88e-06	6.96e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CYCS—hematologic cancer	2.84e-06	6.86e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MAPK8—hematologic cancer	2.82e-06	6.83e-05	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PIK3CA—hematologic cancer	2.82e-06	6.82e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.82e-06	6.82e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—AKT1—hematologic cancer	2.82e-06	6.81e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—EP300—hematologic cancer	2.81e-06	6.8e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PIK3CG—hematologic cancer	2.77e-06	6.7e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—EP300—hematologic cancer	2.75e-06	6.66e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—SRC—hematologic cancer	2.74e-06	6.62e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—SRC—hematologic cancer	2.68e-06	6.47e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—VEGFA—hematologic cancer	2.67e-06	6.44e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—STAT3—hematologic cancer	2.64e-06	6.38e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—NRAS—hematologic cancer	2.63e-06	6.37e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—VEGFA—hematologic cancer	2.61e-06	6.3e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—STAT3—hematologic cancer	2.58e-06	6.24e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—NRAS—hematologic cancer	2.58e-06	6.23e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CREBBP—hematologic cancer	2.57e-06	6.21e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MAPK3—hematologic cancer	2.52e-06	6.1e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.5e-06	6.05e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MAPK3—hematologic cancer	2.47e-06	5.96e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MYC—hematologic cancer	2.45e-06	5.93e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—TGFB1—hematologic cancer	2.45e-06	5.91e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PIK3CD—hematologic cancer	2.44e-06	5.89e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ALB—hematologic cancer	2.4e-06	5.81e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MYC—hematologic cancer	2.4e-06	5.8e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—TGFB1—hematologic cancer	2.39e-06	5.79e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.37e-06	5.73e-05	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—AKT1—hematologic cancer	2.3e-06	5.57e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PIK3R1—hematologic cancer	2.3e-06	5.56e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.3e-06	5.56e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.3e-06	5.56e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—KRAS—hematologic cancer	2.27e-06	5.48e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—KRAS—hematologic cancer	2.22e-06	5.36e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PIK3CB—hematologic cancer	2.12e-06	5.13e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PIK3CA—hematologic cancer	2.08e-06	5.03e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PIK3CA—hematologic cancer	2.04e-06	4.92e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.03e-06	4.91e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—TP53—hematologic cancer	2.01e-06	4.87e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—TP53—hematologic cancer	1.97e-06	4.76e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—HRAS—hematologic cancer	1.93e-06	4.66e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—HRAS—hematologic cancer	1.88e-06	4.56e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—IL6—hematologic cancer	1.84e-06	4.46e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PTEN—hematologic cancer	1.83e-06	4.44e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—IL6—hematologic cancer	1.8e-06	4.36e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—EP300—hematologic cancer	1.75e-06	4.23e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.71e-06	4.13e-05	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—AKT1—hematologic cancer	1.7e-06	4.11e-05	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—AKT1—hematologic cancer	1.66e-06	4.02e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.58e-06	3.83e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.5e-06	3.63e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ALB—hematologic cancer	1.48e-06	3.58e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.42e-06	3.43e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.31e-06	3.16e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.29e-06	3.13e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PTEN—hematologic cancer	1.13e-06	2.73e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—EP300—hematologic cancer	1.08e-06	2.61e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—AKT1—hematologic cancer	1.06e-06	2.56e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PIK3CA—hematologic cancer	7.97e-07	1.93e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—AKT1—hematologic cancer	6.51e-07	1.57e-05	CbGpPWpGaD
